Next Science Ltd (OTCPK:NXSCF)
$ 0.1496 -0.0329 (-18.03%) Market Cap: 47.70 Mil Enterprise Value: 39.39 Mil PE Ratio: 0 PB Ratio: 2.99 GF Score: 50/100

Half Year 2021 Next Science Ltd Earnings Call Transcript

Aug 30, 2021 / 12:30AM GMT
Release Date Price: $1.05 (-0.94%)
Operator

Thank you for standing by, and welcome to the Next Science Limited 2021 Half Year Results Conference Call. (Operator Instructions)

I would now like to hand the conference over to Ms. Judith Mitchell, Managing Director. Please go ahead.

Judith Mitchell
Next Science Limited - MD, CEO & Executive Director

Good morning, and thank you for joining the Next Science results call for the first half of 2021. As you know, Next Science is a company whose purpose is to improve people's health by eliminating or preventing infections. Through our unique technologies, we have helped tens of thousands of people resume normal life. And as we increase our focus on infection prevention, we look forward to the opportunity of quietly protecting millions of people from the complications of postoperative infection.

Moving to Slide 3, in this report I'll focus on our platform technology and products, the execution milestones we've achieved in the last half and the progress we're making in attaining VAC approvals to commercialize XPerience, our market-leading, No

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot